181 related articles for article (PubMed ID: 29206496)
21. Improving the solubility of ampelopsin by solid dispersions and inclusion complexes.
Ruan LP; Yu BY; Fu GM; Zhu DN
J Pharm Biomed Anal; 2005 Jul; 38(3):457-64. PubMed ID: 15925247
[TBL] [Abstract][Full Text] [Related]
22. Electrosprayed Polymeric Nanospheres for Enhanced Solubility, Dissolution Rate, Oral Bioavailability and Antihyperlipidemic Activity of Bezafibrate.
Sun R; Shen C; Shafique S; Mustapha O; Hussain T; Khan IU; Mehmood Y; Anwer K; Shahzad Y; Yousaf AM
Int J Nanomedicine; 2020; 15():705-715. PubMed ID: 32099359
[TBL] [Abstract][Full Text] [Related]
23. Characterization and stability of solid dispersions based on PEG/polymer blends.
Bley H; Fussnegger B; Bodmeier R
Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875
[TBL] [Abstract][Full Text] [Related]
24. Characteristics of rofecoxib-polyethylene glycol 4000 solid dispersions and tablets based on solid dispersions.
Liu C; Desai KG
Pharm Dev Technol; 2005; 10(4):467-77. PubMed ID: 16370176
[TBL] [Abstract][Full Text] [Related]
25. Properties of solid dispersions of piroxicam in polyvinylpyrrolidone.
Tantishaiyakul V; Kaewnopparat N; Ingkatawornwong S
Int J Pharm; 1999 Apr; 181(2):143-51. PubMed ID: 10370210
[TBL] [Abstract][Full Text] [Related]
26. Physicochemical characterisation, drug polymer dissolution and in vitro evaluation of phenacetin and phenylbutazone solid dispersions with polyethylene glycol 8000.
Khan S; Batchelor H; Hanson P; Perrie Y; Mohammed AR
J Pharm Sci; 2011 Oct; 100(10):4281-94. PubMed ID: 21560130
[TBL] [Abstract][Full Text] [Related]
27. An Approach to Enhance Dissolution Rate of Tamoxifen Citrate.
SreeHarsha N; Hiremath JG; Chilukuri S; Aitha RK; Al-Dhubiab BE; Venugopala KN; Alzahrani AM; Meravanige G
Biomed Res Int; 2019; 2019():2161348. PubMed ID: 30800663
[TBL] [Abstract][Full Text] [Related]
28. Stability and Bioavailability Enhancement of Telmisartan Ternary Solid Dispersions: the Synergistic Effect of Polymers and Drug-Polymer(s) Interactions.
Shi X; Xu T; Huang W; Fan B; Sheng X
AAPS PharmSciTech; 2019 Mar; 20(4):143. PubMed ID: 30887265
[TBL] [Abstract][Full Text] [Related]
29. Preparation, characterization and tableting of cilnidipine solid dispersions.
Hu L; Song W; Niu F; Jiao K; Jia Z
Pak J Pharm Sci; 2013 May; 26(3):629-36. PubMed ID: 23625441
[TBL] [Abstract][Full Text] [Related]
30. Preparation and evaluation of solid dispersions of a new antitumor compound based on early-stage preparation discovery concept.
Hou P; Ni J; Cao S; Lei H; Cai Z; Zhang T; Yu F; Tan Q
AAPS PharmSciTech; 2013 Jun; 14(2):629-38. PubMed ID: 23636816
[TBL] [Abstract][Full Text] [Related]
31. Effect of hydrophilic polymers on isradipine complexation with hydroxypropyl β-cyclodextrin.
Mummidi V; Jayanthi V
Drug Dev Ind Pharm; 2013 Jul; 39(7):970-7. PubMed ID: 22612875
[TBL] [Abstract][Full Text] [Related]
32. Use of the co-grinding method to enhance the dissolution behavior of a poorly water-soluble drug: generation of solvent-free drug-polymer solid dispersions.
Yang C; Xu X; Wang J; An Z
Chem Pharm Bull (Tokyo); 2012; 60(7):837-45. PubMed ID: 22790815
[TBL] [Abstract][Full Text] [Related]
33. Formulation, characterization and and evaluation of aloe-emodin-loaded solid dispersions for dissolution enhancement.
Xiuyan LI; Yuting L; Jinhui W; Zhimin DU
J Tradit Chin Med; 2024 Feb; 44(1):54-62. PubMed ID: 38213239
[TBL] [Abstract][Full Text] [Related]
34. In vitro and in vivo studies on a novel solid dispersion of repaglinide using polyvinylpyrrolidone as the carrier.
Yin LF; Huang SJ; Zhu CL; Zhang SH; Zhang Q; Chen XJ; Liu QW
Drug Dev Ind Pharm; 2012 Nov; 38(11):1371-80. PubMed ID: 22296267
[TBL] [Abstract][Full Text] [Related]
35. Solid-state characterization and dissolution properties of meloxicam-moringa coagulant-PVP ternary solid dispersions.
Noolkar SB; Jadhav NR; Bhende SA; Killedar SG
AAPS PharmSciTech; 2013 Jun; 14(2):569-77. PubMed ID: 23483432
[TBL] [Abstract][Full Text] [Related]
36. Preparation and characterization of domperidone solid dispersions.
Essa EA; Balata GF
Pak J Pharm Sci; 2012 Oct; 25(4):783-91. PubMed ID: 23009995
[TBL] [Abstract][Full Text] [Related]
37. Development of prednisone:polyethylene glycol 6000 fast-release tablets from solid dispersions: solid-state characterization, dissolution behavior, and formulation parameters.
Leonardi D; Barrera MG; Lamas MC; Salomón CJ
AAPS PharmSciTech; 2007 Dec; 8(4):E108. PubMed ID: 18181529
[TBL] [Abstract][Full Text] [Related]
38. In vitro dissolution and physicochemical characterizations of novel PVP-based solid dispersions containing valsartan prepared by a freeze-drying method.
Xu WJ; Liu Y; Shi LL; Cui JH; Cao QR
Pak J Pharm Sci; 2014 Nov; 27(6):1799-804. PubMed ID: 25362604
[TBL] [Abstract][Full Text] [Related]
39. New metastable form of glibenclamide prepared by redispersion from ternary solid dispersions containing polyvinylpyrrolidone-K30 and sodium lauryl sulfate.
Thongnopkoon T; Puttipipatkhachorn S
Drug Dev Ind Pharm; 2016 Jan; 42(1):70-79. PubMed ID: 25835067
[TBL] [Abstract][Full Text] [Related]
40. Development of PVP/PEG mixtures as appropriate carriers for the preparation of drug solid dispersions by melt mixing technique and optimization of dissolution using artificial neural networks.
Barmpalexis P; Koutsidis I; Karavas E; Louka D; Papadimitriou SA; Bikiaris DN
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1219-31. PubMed ID: 23541514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]